MINNEAPOLIS--(BUSINESS WIRE)--May 11, 2006--Medtronic, Inc. (NYSE:MDT - News) today announced its schedule of major activities for the Paris Course on Revascularization (EuroPCR), which begins May 16 at the Palais des Congres in Paris. On the first day of the meeting, Medtronic's Vascular division will present long-term data on the Endeavor(TM) drug-eluting coronary stent from the ENDEAVOR I and ENDEAVOR II clinical trials. In addition, Medtronic will host physician symposia on chronic total occlusions (CTO) and drug-eluting stent safety, as well as sponsor a variety of case review and educational sessions. The schedule of activities includes the following:
